Tandem Diabetes Care, Inc. (0M0F.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 02:53PM BST. Market open.
| Previous close | 35.27 |
| Open | 35.32 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 34.89 - 35.32 |
| 52-week range | 13.89 - 43.04 |
| Volume | |
| Avg. volume | 681 |
| Market cap | 19.853M |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | 3.94 |
| EPS (TTM) | 0.09 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksEarnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
Tandem Diabetes Care (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireTandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
SAN DIEGO, April 09, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results.
Simply Wall St.Bullish Tandem Diabetes Care Insiders Loaded Up On US$725.5k Of Stock
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
© 2024 Yahoo. All rights reserved.